Elite Pharmaceuticals, Inc. (ELTP)
0.2891
-0.01
(-2.00%)
USD |
OTCM |
Aug 24, 16:00
Elite Pharmaceuticals Total Assets (Quarterly) : 139.67M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 139.67M |
| March 31, 2026 | 139.80M |
| December 31, 2025 | 126.41M |
| September 30, 2025 | 117.25M |
| June 30, 2025 | 111.34M |
| March 31, 2025 | 96.39M |
| December 31, 2024 | 90.76M |
| September 30, 2024 | 88.20M |
| June 30, 2024 | 87.85M |
| March 31, 2024 | 83.65M |
| December 31, 2023 | 74.70M |
| September 30, 2023 | 70.72M |
| June 30, 2023 | 46.50M |
| March 31, 2023 | 40.90M |
| December 31, 2022 | 52.72M |
| September 30, 2022 | 50.34M |
| June 30, 2022 | 48.11M |
| March 31, 2022 | 35.15M |
| December 31, 2021 | 31.95M |
| September 30, 2021 | 30.62M |
| June 30, 2021 | 29.99M |
| March 31, 2021 | 26.19M |
| December 31, 2020 | 28.67M |
| September 30, 2020 | 27.61M |
| June 30, 2020 | 27.82M |
| Date | Value |
|---|---|
| March 31, 2020 | 24.96M |
| December 31, 2019 | 24.09M |
| September 30, 2019 | 23.53M |
| June 30, 2019 | 24.28M |
| March 31, 2019 | 24.40M |
| December 31, 2018 | 26.38M |
| September 30, 2018 | 27.32M |
| June 30, 2018 | 28.50M |
| March 31, 2018 | 30.88M |
| December 31, 2017 | 32.07M |
| September 30, 2017 | 32.01M |
| June 30, 2017 | 33.89M |
| March 31, 2017 | 34.31M |
| December 31, 2016 | 36.20M |
| September 30, 2016 | 34.87M |
| June 30, 2016 | 33.06M |
| March 31, 2016 | 31.88M |
| December 31, 2015 | 27.13M |
| September 30, 2015 | 28.70M |
| June 30, 2015 | 29.91M |
| March 31, 2015 | 25.92M |
| December 31, 2014 | 25.70M |
| September 30, 2014 | 23.89M |
| June 30, 2014 | 23.97M |
| March 31, 2014 | 24.32M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Nektar Therapeutics | 1.095B |
| Daré Bioscience, Inc. | 22.37M |
| Eton Pharmaceuticals, Inc. | 115.81M |
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 34.84M |
| Shareholders Equity (Quarterly) | 104.83M |
| Debt to Equity Ratio | 0.0532 |
| Current Ratio | 3.761 |
| Net Debt Paydown Yield | 0.27% |